Program index

Training Day, Wednesday May 29

SESSION T1 T1:101, T1:102, T1:103
SESSION T2 T2:101, T2:102, T2:103, T2:104, T2:105, T2:106, T2:107, T2:108
SESSION T3 T3:101, T3:102
SESSION T4 T4:101, T4:102, T4:103, T4:104, T4:105, T4:106
SESSION T5 T5:101, T5:102, T5:103, T5:104, T5:105, T5:106
SESSION T6 T6:101, T6:102, T6:103, T6:104, T6:105, T6:106
SESSION T7 T7:101, T7:102, T7:103

Congress Day 1, Thursday May 30

PLENARY 1 O1:101, O1:102, O1:103, O1:104, O1:105, O1:106, O1:107, O1:108, O1:109
JOHAN JANSSON MEMORIAL GUEST LECTURE: MGL1:101
PLENARY 2 O2:101, O2:102, O2:103, O2:104, O2:105, O2:106
PLENARY 3 O3:101, O3:102, O3:103, O3:104, O3:105, O3:106, O3:107, O3:108
PLENARY 4 O4:101, O4:102, O4:103, O4:104, O4:105, O4:106, O4:107
PLENARY 5 O5:101, O5:102, O5:103, O5:104, O5:105, O5:106, O5:107, O5:108, O5:109
PLENARY 6 O6:101, O6:102, O6:103, O6:104, O6:105, O6:106, O6:107, O6:108, O6:109, O6:110
POSTER REVIEW PSR:101, PSR:102, PSR:103, PSR:104, PSR:105, PSR:106, PSR:107, PSR:108, PSR:109, PSR:110

Congress Day 2, Friday May 31

PLENARY 7 O7:101, O7:102, O7:103, O7:104, O7:105, O7:106, O7:107, O7:108, O7:109, O7:110, O7:111, O7:112, O7:113, O7:114
THE BERTIL STENER MEMORIAL GUEST LECTURE: MGL2:101
PLENARY 8 O8:101, O8:102, O8:103, O8:104, O8:105, O8:106, O8:107, O8:108
PLENARY 9 O9:101, O9:102, O9:103, O9:104, O9:105, O9:106, O9:107, O9:108, O9:109, O9:110
PLENARY 10 O10:101, O10:102, O10:103, O10:104, O10:105, O10:106
PLENARY 11 O11:101, O11:102, O11:103, O11:104
PLENARY 12 O12:101, O12:102
PLENARY 13 O13:101, O13:102, O13:103

 

Poster Groups

GROUP 1 – BASIC SARCOMA SCIENCE

P1:101, P1:102, P1:103, P1:104, P1:105, P1:106, P1:107, P1:108

P2:101, P2:102, P2:103, P2:104, P2:105, P2:106, P2:107, P2:108, P2:109, P2:110, P2:111, P2:112

P4:101, P4:102, P4:103

GROUP 2 – DIAGNOSTICS IN BONE AND SOFT TISSUE TUMORS

P5:101, P5:102, P5:103, P5:104, P5:105, P5:106, P5:107, P5:108, P5:109

P6:101, P6:102, P6:103, P6:104, P6:105, P6:106, P6:107, P6:108, P6:109, P6:110, P6:111, P6:112, P6:113, P6:114, P6:115, P6:116, P6:117, P6:118

P7:101, P7:102, P7:103, P7:104, P7:105, P7:106, P7:107, P7:108, P7:109, P7:110, P7:111, P7:112, P7:113, P7:114, P7:115, P7:116, P7:117, P7:118
P9:101, P9:102

GROUP 3 – TREATMENT MODALITIES IN MUSCULOSKELETAL TUMORS

P10:101, P10:102, P10:103, P10:104

P11:101, P11:102, P11:103

P12:101

P13:101, P13:102, P13:103

P14:101

GROUP 4 – SURGICAL RECONSTRUCTIONS & COMPLICATIONS

P15:101, P15:102, P15:103, P15:104, P15:105, P15:106, P15:107, P15:108, P15:109, P15:110, P15:111, P15:112, P15:113, P15:114, P15:115, P15:116, P15:117, P15:118, P15:119, P15:120, P15:121, P15:122,P15:123, P15:124, P15:125

P16:101, P16:102, P16:103, P16:104, P16:105, P16:106

P17:101, P17:102

GROUP 5 – MANAGEMENT OF METASTASIS AND BONE & SOFT TISSUE TUMORS

P18:101, P18:102, P18:103, P18:104

P19:101, P19:102, P19:103, P19:104, P19:105, P19:106, P19:107, P19:108, P19:109, P19:110, P19:111

P20:101, P20:102, P20:103, P20:104, P20:105, P20:106, P20:107, P20:108, P20:109, P20:110

Kongress.se